Research Summary
Glucagon is a peptide hormone produced by the alpha cells of the pancreas, and it plays a crucial role in regulating blood glucose levels in the body. It acts in opposition to insulin, promoting the release of glucose from the liver into the bloodstream (glycogenolysis) and stimulating the conversion of other substrates into glucose (gluconeogenesis). Glucagon acts primarily in response to low blood sugar levels, signaling the liver to release stored glucose to elevate blood glucose levels, ensuring a steady supply of energy for the body. This hormone is vital in maintaining glucose homeostasis, and an imbalance in the insulin-glucagon axis can contribute to conditions such as diabetes. In clinical settings, synthetic glucagon is sometimes administered to raise blood sugar levels in emergency situations, such as severe hypoglycemia, where rapid glucose mobilization is necessary.
According to DIResearch's in-depth investigation and research, the global Glucagon market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Glucagon include Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, Xeris Pharmaceuticals, Taj Pharmaceuticals etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Glucagon. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Glucagon market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Glucagon market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Glucagon industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Glucagon Include:
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Xeris Pharmaceuticals
Taj Pharmaceuticals
Glucagon Product Segment Include:
Inject Glucagon
Nasal Glucagon
Glucagon Product Application Include:
Emergency Kits
General Use
Diagnostic & Motility
Cardiogenic Shock
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Glucagon Industry PESTEL Analysis
Chapter 3: Global Glucagon Industry Porter's Five Forces Analysis
Chapter 4: Global Glucagon Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Glucagon Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Glucagon Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Glucagon Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Glucagon Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Glucagon Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Glucagon Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Glucagon Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Glucagon Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Glucagon Market Overview 1.1 Product Definition and Statistical Scope 1.2 Glucagon Product by Type 1.2.1 Global Glucagon Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Inject Glucagon 1.2.3 Nasal Glucagon 1.3 Glucagon Product by Application 1.3.1 Global Glucagon Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Emergency Kits 1.3.3 General Use 1.3.4 Diagnostic & Motility 1.3.5 Cardiogenic Shock 1.3.6 Others 1.4 Global Glucagon Market Revenue and Sales Analysis 1.4.1 Global Glucagon Market Size Analysis (2019-2030) 1.4.2 Global Glucagon Market Sales Analysis (2019-2030) 1.4.3 Global Glucagon Market Sales Price Trend Analysis (2019-2030) 1.5 Glucagon Market Development Status and Trends 1.5.1 Glucagon Industry Development Status Analysis 1.5.2 Glucagon Industry Development Trends Analysis 2 Glucagon Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Glucagon Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Glucagon Market Analysis by Regions 4.1 Glucagon Overall Market: 2023 VS 2024 VS 2030 4.2 Global Glucagon Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Glucagon Revenue and Market Share by Region (2019-2024) 4.2.2 Global Glucagon Revenue Forecast by Region (2025-2030) 4.3 Global Glucagon Sales and Forecast Analysis (2019-2030) 4.3.1 Global Glucagon Sales and Market Share by Region (2019-2024) 4.3.2 Global Glucagon Sales Forecast by Region (2025-2030) 4.4 Global Glucagon Sales Price Trend Analysis (2019-2030) 5 Global Glucagon Market Size by Type and Application 5.1 Global Glucagon Market Size by Type 5.1.1 Global Glucagon Revenue and Forecast Analysis by Type (2019-2030) 5.1.2 Global Glucagon Sales and Forecast Analysis by Type (2019-2030) 5.2 Global Glucagon Market Size by Application 5.2.1 Global Glucagon Revenue and Forecast Analysis by Application (2019-2030) 5.2.2 Global Glucagon Sales and Forecast Analysis by Application (2019-2030) 6 North America 6.1 North America Glucagon Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Glucagon Market Size by Type 6.3.1 North America Glucagon Sales by Type (2019-2030) 6.3.2 North America Glucagon Revenue by Type (2019-2030) 6.4 North America Glucagon Market Size by Application 6.4.1 North America Glucagon Sales by Application (2019-2030) 6.4.2 North America Glucagon Revenue by Application (2019-2030) 6.5 North America Glucagon Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Glucagon Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Glucagon Market Size by Type 7.3.1 Europe Glucagon Sales by Type (2019-2030) 7.3.2 Europe Glucagon Revenue by Type (2019-2030) 7.4 Europe Glucagon Market Size by Application 7.4.1 Europe Glucagon Sales by Application (2019-2030) 7.4.2 ? Europe Glucagon Revenue by Application (2019-2030) 7.5 Europe Glucagon Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Glucagon Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Glucagon Market Size by Type 8.3.1 China Glucagon Sales by Type (2019-2030) 8.3.2 China Glucagon Revenue by Type (2019-2030) 8.4 China Glucagon Market Size by Application 8.4.1 China Glucagon Sales by Application (2019-2030) 8.4.2 China Glucagon Revenue by Application (2019-2030) 9 APAC (excl. China) 9.1 APAC (excl. China) Glucagon Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Glucagon Market Size by Type 9.3.1 APAC (excl. China) Glucagon Sales by Type (2019-2030) 9.3.2 APAC (excl. China) Glucagon Revenue by Type (2019-2030) 9.4 APAC (excl. China) Glucagon Market Size by Application 9.4.1 APAC (excl. China) Glucagon Sales by Application (2019-2030) 9.4.2 APAC (excl. China) Glucagon Revenue by Application (2019-2030) 9.5 APAC (excl. China) Glucagon Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Glucagon Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Glucagon Market Size by Type 10.3.1 Latin America Glucagon Sales by Type (2019-2030) 10.3.2 Latin America Glucagon Revenue by Type (2019-2030) 10.4 Latin America Glucagon Market Size by Application 10.4.1 Latin America Glucagon Sales by Application (2019-2030) 10.4.2 Latin America Glucagon Revenue by Application (2019-2030) 10.5 Latin America Glucagon Market Size by Country 10.5.1 Mexico 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Glucagon Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Glucagon Market Size by Type 11.3.1 Middle East & Africa Glucagon Sales by Type (2019-2030) 11.3.2 Middle East & Africa Glucagon Revenue by Type (2019-2030) 11.4 Middle East & Africa Glucagon Market Size by Application 11.4.1 Middle East & Africa Glucagon Sales by Application (2019-2030) 11.4.2 Middle East & Africa Glucagon Revenue by Application (2019-2030) 11.5 Middle East & Africa Glucagon Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Competition by Manufacturers 12.1 Global Glucagon Market Sales, Revenue and Price by Key Manufacturers (2020-2024) 12.1.1 Global Glucagon Market Sales by Key Manufacturers (2020-2024) 12.1.2 Global Glucagon Market Revenue by Key Manufacturers (2020-2024) 12.1.3 Global Glucagon Average Sales Price by Manufacturers (2020-2024) 12.2 Glucagon Competitive Landscape Analysis and Market Dynamic 12.2.1 Glucagon Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Novo Nordisk 13.1.1 Novo Nordisk Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Novo Nordisk Glucagon Product Portfolio 13.1.3 Novo Nordisk Glucagon Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.2 Eli Lilly 13.2.1 Eli Lilly Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Eli Lilly Glucagon Product Portfolio 13.2.3 Eli Lilly Glucagon Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.3 Fresenius Kabi 13.3.1 Fresenius Kabi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Fresenius Kabi Glucagon Product Portfolio 13.3.3 Fresenius Kabi Glucagon Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.4 Torrent Labs 13.4.1 Torrent Labs Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Torrent Labs Glucagon Product Portfolio 13.4.3 Torrent Labs Glucagon Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.5 Xeris Pharmaceuticals 13.5.1 Xeris Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Xeris Pharmaceuticals Glucagon Product Portfolio 13.5.3 Xeris Pharmaceuticals Glucagon Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.6 Taj Pharmaceuticals 13.6.1 Taj Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Taj Pharmaceuticals Glucagon Product Portfolio 13.6.3 Taj Pharmaceuticals Glucagon Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Glucagon Industry Chain Analysis 14.2 Glucagon Industry Upstream Supply Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Glucagon Typical Downstream Customers 14.4 Glucagon Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support